Yordi J van de Vegte
Overview
Explore the profile of Yordi J van de Vegte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allara E, Bell S, Smith R, Keene S, Gill D, Gaziano L, et al.
Commun Biol
. 2024 Dec;
7(1):1631.
PMID: 39643614
Iron homoeostasis is tightly regulated, with hepcidin and soluble transferrin receptor (sTfR) playing significant roles. However, the genetic determinants of these traits and the biomedical consequences of iron homoeostasis variation...
2.
Yeung M, Said M, van de Vegte Y, Verweij N, Dullaart R, van der Harst P
Atheroscler Plus
. 2024 Aug;
57:19-25.
PMID: 39109317
Background And Aims: We aimed to study the association of very low serum Lipoprotein(a) [Lp(a)] concentrations with new-onset type 2 diabetes (T2D) and non-alcoholic liver disease (NAFLD) in the context...
3.
Kahnert K, Soattin L, Mills R, Wilson C, Maurya S, Sorrentino A, et al.
Cardiovasc Res
. 2024 Apr;
120(8):927-942.
PMID: 38661182
Aims: In patients with heart failure (HF), concomitant sinus node dysfunction (SND) is an important predictor of mortality, yet its molecular underpinnings are poorly understood. Using proteomics, this study aimed...
4.
Al Ali L, van de Vegte Y, Said M, Groot H, Hendriks T, Yeung M, et al.
Sci Rep
. 2023 Dec;
13(1):21469.
PMID: 38052855
Fetuin-A acts as both an inhibitor of calcification and insulin signaling. Previous studies reported conflicting results on the association between fetuin-A and cardiometabolic diseases. We aim to provide further insights...
5.
van de Vegte Y, Eppinga R, van der Ende M, Hagemeijer Y, Mahendran Y, Salfati E, et al.
Nat Commun
. 2023 Aug;
14(1):4646.
PMID: 37532724
Resting heart rate is associated with cardiovascular diseases and mortality in observational and Mendelian randomization studies. The aims of this study are to extend the number of resting heart rate...
6.
Benjamins J, Yeung M, van de Vegte Y, Said M, van der Linden T, Ties D, et al.
EBioMedicine
. 2021 Dec;
75:103783.
PMID: 34968759
Background: Alterations in the anatomic and biomechanical properties of the ascending aorta (AAo) can give rise to various vascular pathologies. The aim of the current study is to gain additional...
7.
Yeung M, Wang S, van de Vegte Y, Borisov O, van Setten J, Snieder H, et al.
Arterioscler Thromb Vasc Biol
. 2021 Dec;
42(4):484-501.
PMID: 34852643
Objective: Carotid artery intima-media thickness (cIMT) is a widely accepted marker of subclinical atherosclerosis. Twenty susceptibility loci for cIMT were previously identified and the identification of additional susceptibility loci furthers...
8.
Wang S, Said M, Groot H, van der Most P, Thio C, van de Vegte Y, et al.
Genes (Basel)
. 2021 Aug;
12(8).
PMID: 34440348
SGLT2 inhibitors (SGLT2i) block renal glucose reabsorption. Due to the unexpected beneficial observations in type 2 diabetic patients potentially related to increased natriuresis, SGLT2i are also studied for heart failure...
9.
van de Vegte Y, Siland J, Rienstra M, van der Harst P
Sci Rep
. 2021 Apr;
11(1):8431.
PMID: 33875748
Atrial fibrillation (AF) patients have enlarged left atria (LA), but prior studies suggested enlarged atria as both cause and consequence of AF. The aim of this study is to investigate...
10.
Said M, Yeung M, van de Vegte Y, Benjamins J, Dullaart R, Ruotsalainen S, et al.
Arterioscler Thromb Vasc Biol
. 2021 Mar;
41(5):1792-1800.
PMID: 33730874
[Figure: see text].